The global lab on chip market size was estimated at around USD 7.49 billion in 2022 and it is projected to hit around USD 17.78 billion by 2032, growing at a CAGR of 9.03% from 2023 to 2032.
Key Pointers
Report Scope of the Lab on Chip Market
Report Coverage | Details |
Market Size in 2022 | USD 7.49 billion |
Revenue Forecast by 2032 | USD 17.78 billion |
Growth rate from 2023 to 2032 | CAGR of 9.03% |
Base Year | 2022 |
Forecast Period | 2023 to 2032 |
Regions Covered | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
Companies Covered | Micronit, MIMETAS, BEOnChip, Nortis Bio, TisssUse, InSphero, Elvesys, Mesobiotech, AxoSim, Emulate Bio, Tara Biosystems, Hepregen, Hurel Corporation, Cherry Biotech, Alveolix, BiomimiX, BioIVT, 4D Cell, Fluigent |
Key factors driving Lab-on-a-chip market revenue growth include increasing demand for point of care testing , rising incidence of chronic diseases, and expanding applications of genomics and proteomics in cancer research. Proteomics is widely adopted for drug discovery and biomarkers. Rise in demand for personalized medicines is further driving lab-on-a-chip market revenue growth, and the trend is expected to continue going ahead.
Increasing prevalence of cancer is a leading factor among the other major factors driving revenue growth of the lab-on-a-chip market. LOC devices are used in detection of pathogens, and also for biomarker-based identification and early diagnosis of oral cancer. High incidence of swine flu, malaria, Ebola virus and Zika virus are also fueling demand for LOC, and in turn fueling market revenue growth. Lab-on-a-chip technology is under exploration for applications in other areas by various small- to medium-sized enterprises, primarily in countries in North America, Asia, and Europe. Adoption of Lab-on-a-chip has been relatively low across a range of application areas. Poor reproducibility and inconsistency of results using LOC is hampering growth of the market to a certain extent.
The global Lab-on-a-chip market is gaining traction due to increased investment in research & development in pharmaceuticals, life sciences, and personalized medicine. Furthermore, several microfluidic device companies are entering into partnerships and collaborations to develop more innovative Lab-on-a-chip solutions, which is also fueling growth of the market. Advancements in technology and research in miniaturization of LOC will further drive revenue drive growth of the market going ahead. However, advancements in technology has been leading to development of more advanced technologies and assays, which are capable of early and easy detection of pathogenicity and development in drug discovery, which will drive traction of this technology going ahead.
Lab-on-a-chip-based devices are an integration of several disciplines and miniaturization of laboratory procedures. These devices are branching out into additional aspects of healthcare such as stem cell, drug delivery, synthetic biology, and environmental monitoring owing to high level of integration required to develop LOC devices. Chronic diseases are on the rise globally. Rapidly increasing global geriatric population and changes in societal behavior are also leading to a steady increase in prevalence of more common and expensive long-term health problems. Furthermore, adoption of Lab-on-a-chip in the diagnosis of chronic diseases and infections is driving revenue growth of the global lab-on-a-chip market, and the trend is expected to continue at a steady pace over the forecast period.
Lab on Chip Market Segmentations:
By Product | By Technology | By Application | By End-Use |
Reagents & Consumables Software IV Needles |
Microarrays Microfluidics Tissue Biochip Others |
Genomics Proteomics Point of Care Diagnostics Drug Discovery Others |
Hospitals and Clinics Biotechnology and Pharmaceuticals Companies Forensic Laboratories Diagnostics Centers Academic and Research Institutes |
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Lab on Chip Market
5.1. COVID-19 Landscape: Lab on Chip Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Lab on Chip Market, By Product
8.1. Lab on Chip Market, by Product, 2023-2032
8.1.1. Reagents & Consumables
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Software
8.1.2.1. Market Revenue and Forecast (2020-2032)
8.1.3. IV Needles
8.1.3.1. Market Revenue and Forecast (2020-2032)
Chapter 9. Global Lab on Chip Market, By Technology
9.1. Lab on Chip Market, by Technology, 2023-2032
9.1.1. Microarrays
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Microfluidics
9.1.2.1. Market Revenue and Forecast (2020-2032)
9.1.3. Tissue Biochip
9.1.3.1. Market Revenue and Forecast (2020-2032)
9.1.4. Others
9.1.4.1. Market Revenue and Forecast (2020-2032)
Chapter 10. Global Lab on Chip Market, By Application
10.1. Lab on Chip Market, by Application, 2023-2032
10.1.1. Genomics
10.1.1.1. Market Revenue and Forecast (2020-2032)
10.1.2. Proteomics
10.1.2.1. Market Revenue and Forecast (2020-2032)
10.1.3. Point of Care Diagnostics
10.1.3.1. Market Revenue and Forecast (2020-2032)
10.1.4. Drug Discovery
10.1.4.1. Market Revenue and Forecast (2020-2032)
10.1.5. Others
10.1.5.1. Market Revenue and Forecast (2020-2032)
Chapter 11. Global Lab on Chip Market, By End-Use
11.1. Lab on Chip Market, by End-Use, 2023-2032
11.1.1. Hospitals and Clinics
11.1.1.1. Market Revenue and Forecast (2020-2032)
11.1.2. Biotechnology and Pharmaceuticals Companies
11.1.2.1. Market Revenue and Forecast (2020-2032)
11.1.3. Forensic Laboratories
11.1.3.1. Market Revenue and Forecast (2020-2032)
11.1.4. Diagnostics Centers
11.1.4.1. Market Revenue and Forecast (2020-2032)
11.1.5. Academic and Research Institutes
11.1.5.1. Market Revenue and Forecast (2020-2032)
Chapter 12. Global Lab on Chip Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Product (2020-2032)
12.1.2. Market Revenue and Forecast, by Technology (2020-2032)
12.1.3. Market Revenue and Forecast, by Application (2020-2032)
12.1.4. Market Revenue and Forecast, by End-Use (2020-2032)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Product (2020-2032)
12.1.5.2. Market Revenue and Forecast, by Technology (2020-2032)
12.1.5.3. Market Revenue and Forecast, by Application (2020-2032)
12.1.5.4. Market Revenue and Forecast, by End-Use (2020-2032)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Product (2020-2032)
12.1.6.2. Market Revenue and Forecast, by Technology (2020-2032)
12.1.6.3. Market Revenue and Forecast, by Application (2020-2032)
12.1.6.4. Market Revenue and Forecast, by End-Use (2020-2032)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Product (2020-2032)
12.2.2. Market Revenue and Forecast, by Technology (2020-2032)
12.2.3. Market Revenue and Forecast, by Application (2020-2032)
12.2.4. Market Revenue and Forecast, by End-Use (2020-2032)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Product (2020-2032)
12.2.5.2. Market Revenue and Forecast, by Technology (2020-2032)
12.2.5.3. Market Revenue and Forecast, by Application (2020-2032)
12.2.5.4. Market Revenue and Forecast, by End-Use (2020-2032)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Product (2020-2032)
12.2.6.2. Market Revenue and Forecast, by Technology (2020-2032)
12.2.6.3. Market Revenue and Forecast, by Application (2020-2032)
12.2.6.4. Market Revenue and Forecast, by End-Use (2020-2032)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Product (2020-2032)
12.2.7.2. Market Revenue and Forecast, by Technology (2020-2032)
12.2.7.3. Market Revenue and Forecast, by Application (2020-2032)
12.2.7.4. Market Revenue and Forecast, by End-Use (2020-2032)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Product (2020-2032)
12.2.8.2. Market Revenue and Forecast, by Technology (2020-2032)
12.2.8.3. Market Revenue and Forecast, by Application (2020-2032)
12.2.8.4. Market Revenue and Forecast, by End-Use (2020-2032)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Product (2020-2032)
12.3.2. Market Revenue and Forecast, by Technology (2020-2032)
12.3.3. Market Revenue and Forecast, by Application (2020-2032)
12.3.4. Market Revenue and Forecast, by End-Use (2020-2032)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Product (2020-2032)
12.3.5.2. Market Revenue and Forecast, by Technology (2020-2032)
12.3.5.3. Market Revenue and Forecast, by Application (2020-2032)
12.3.5.4. Market Revenue and Forecast, by End-Use (2020-2032)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Product (2020-2032)
12.3.6.2. Market Revenue and Forecast, by Technology (2020-2032)
12.3.6.3. Market Revenue and Forecast, by Application (2020-2032)
12.3.6.4. Market Revenue and Forecast, by End-Use (2020-2032)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Product (2020-2032)
12.3.7.2. Market Revenue and Forecast, by Technology (2020-2032)
12.3.7.3. Market Revenue and Forecast, by Application (2020-2032)
12.3.7.4. Market Revenue and Forecast, by End-Use (2020-2032)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Product (2020-2032)
12.3.8.2. Market Revenue and Forecast, by Technology (2020-2032)
12.3.8.3. Market Revenue and Forecast, by Application (2020-2032)
12.3.8.4. Market Revenue and Forecast, by End-Use (2020-2032)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Product (2020-2032)
12.4.2. Market Revenue and Forecast, by Technology (2020-2032)
12.4.3. Market Revenue and Forecast, by Application (2020-2032)
12.4.4. Market Revenue and Forecast, by End-Use (2020-2032)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Product (2020-2032)
12.4.5.2. Market Revenue and Forecast, by Technology (2020-2032)
12.4.5.3. Market Revenue and Forecast, by Application (2020-2032)
12.4.5.4. Market Revenue and Forecast, by End-Use (2020-2032)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Product (2020-2032)
12.4.6.2. Market Revenue and Forecast, by Technology (2020-2032)
12.4.6.3. Market Revenue and Forecast, by Application (2020-2032)
12.4.6.4. Market Revenue and Forecast, by End-Use (2020-2032)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Product (2020-2032)
12.4.7.2. Market Revenue and Forecast, by Technology (2020-2032)
12.4.7.3. Market Revenue and Forecast, by Application (2020-2032)
12.4.7.4. Market Revenue and Forecast, by End-Use (2020-2032)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Product (2020-2032)
12.4.8.2. Market Revenue and Forecast, by Technology (2020-2032)
12.4.8.3. Market Revenue and Forecast, by Application (2020-2032)
12.4.8.4. Market Revenue and Forecast, by End-Use (2020-2032)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Product (2020-2032)
12.5.2. Market Revenue and Forecast, by Technology (2020-2032)
12.5.3. Market Revenue and Forecast, by Application (2020-2032)
12.5.4. Market Revenue and Forecast, by End-Use (2020-2032)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Product (2020-2032)
12.5.5.2. Market Revenue and Forecast, by Technology (2020-2032)
12.5.5.3. Market Revenue and Forecast, by Application (2020-2032)
12.5.5.4. Market Revenue and Forecast, by End-Use (2020-2032)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Product (2020-2032)
12.5.6.2. Market Revenue and Forecast, by Technology (2020-2032)
12.5.6.3. Market Revenue and Forecast, by Application (2020-2032)
12.5.6.4. Market Revenue and Forecast, by End-Use (2020-2032)
Chapter 13. Company Profiles
13.1. Micronit
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. MIMETAS
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. BEOnChip
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Nortis Bio
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. TisssUse
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. InSphero
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Elvesys
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Mesobiotech
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. AxoSim
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Emulate Bio
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms